
China SXT Pharmaceuticals SXTC
€ 1.50
-1.68%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
China SXT Pharmaceuticals DPO 2011-2026 | SXTC
DPO Jährlich China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 324 | 353 | 338 | 397 | 320 | 269 | 128 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 397 | 128 | 304 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MannKind Corporation
MNKD
|
108 | $ 3.56 | 24.48 % | $ 1.09 B | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Bio-Techne Corporation
TECH
|
26.9 | $ 47.41 | -16.36 % | $ 7.47 B | ||
|
United Therapeutics Corporation
UTHR
|
6.22 | $ 596.76 | 4.29 % | $ 26.4 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Exelixis
EXEL
|
148 | $ 48.7 | 9.64 % | $ 13.2 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 21.48 | -3.89 % | $ 3.56 B | ||
|
Fortress Biotech
FBIO
|
400 | - | - | $ 71.1 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.15 | 1.19 % | $ 655 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 24.17 | 3.2 % | $ 3.08 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.7 | 3.66 % | $ 452 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
30.3 | - | - | - |